Antigenics, Inc. (NASDAQ:AGEN)
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to raise ahead of data. If they do, expect disappointment ahead.
Recs
they just raised money at 51cents, so that should be a floor for a little while.
Recs
next round of speculative outperformers. very risky (except for the few at the end of the list).
tickers: gkk,anpi,tstr,agen,htm,ddss,vtg,erii,swhc,brnc,chk,bgp,bks,hlcs,cog,jec,gy
Recs
I've been following this company for a while. I feel it's a buy under .90 cents, the vaccine technology in QS-21 and some of their other treatments are the future of vaccines and fighting cancer, and they have the real deal. This company will make Dendreon look small if it can hang on through the clinical trials and doesn't get bought out.
Recs
Great news in next 90 days likely
Recs
This BioPharm is getting hot. I'd say that this company and CVM are nippin at the heals of large sector growth. We should see a double in stock price within a year... but probably more. Give it a few years... and this is a potential billion dollar company in the $20 stock range. Great price to buy!
Recs
seems like a decent stock. only about a million in sales per quarter and a fairly substantial amount of long term debt, but there is promise for both drugs in phase 2.
Recs
How Should I know!
Recs
Time to buy.... stock has finished consolidating... recent upward change to private placement price, plus recent move in stock price confirms big money wants in... should see a nice run as summer ends and we get closer to EMEA decision
Recs
biotech spec
Recs
recent run up looks prime for thumbs down
Recs
You need phase 3 data to get an approval (in this country). :)
Recs
Hopefully FDA approves the export...
Recs
Recs
Chart is looking up! Buying and then selling in a couple weeks when I feel it's peaked
Recs
once sales of this product hit the market and there proven benifits to the vacine i can see this stock grow expotentially.
Recs
Who wouldn't want a vaccine to save their life?
Recs
Will pop up because of the russian approval.
Recs
Russia will become haven for terminal cancer patients.
Recs
it sounds like they have a good chance to stop cancer in the kindey
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 32 : 1 2 Next »